Healthcare Advisory Board Member – The Future of Cognitive Care

Alzheimer's Treatment Centers of America is expanding its precision medicine platform for cognitive decline care and is assembling a Strategic Advisory Board to support that growth. Advisory Board Members work alongside physicians, healthcare innovators, and executive leaders to guide commercialisation, strategic partnerships, and market expansion efforts.

This is a light-touch commitment of approximately one to two hours per month, conducted virtually. Members may be eligible for sweat equity, participation in carried interest programmes, and potential involvement in future investment opportunities with the organisation.

• Provide strategic guidance on organisational growth, commercialisation, reimbursement strategy, and long-term business planning.
• Advise leadership on healthcare innovation, strategic partnerships, and market expansion opportunities.
• Introduce key relationships across healthcare systems, diagnostics, biotechnology, life sciences, and investment communities.
• Participate in periodic virtual Advisory Board meetings and offer ongoing strategic insight.
• Support the advancement of precision medicine and personalised cognitive healthcare initiatives.

• Background in healthcare executive leadership, physician leadership, or healthcare services organisation management.
• Experience in biotechnology, diagnostics, pharmaceuticals, digital health, or medical devices is welcomed.
• Track record in corporate strategy, business development, entrepreneurship, or healthcare innovation.
• Experience in private equity, venture capital, family office investing, or value-based care is an advantage.
• Prior board, advisory board, or governance experience preferred.

Alzheimer's Treatment Centers of America integrates advanced diagnostics, biomarker testing, and genetics to deliver personalised treatment strategies for Alzheimer's disease and cognitive decline. The organisation is building a scalable clinical platform designed to improve patient outcomes and is currently expanding its national footprint.